| Time | Topics | Speaker/s |
|
11:00
-
11:05
|
The Changes of Choroidal Thickness of Patients With Retinal Detachment After Scleral Buckling Surgery Using Enhanced Depth Imaging (EDI)-OCT
|
Leila Rezaei, MD
|
|
11:07
-
11:12
|
Clinical Study of the Effect of Sprinolactone as a Treatment for Acute Central Serous Chorio-Retinopathy (CSCR) in Patients Referring to Shahid Sadoughi Hospital of Yazd from 2014 to 2015
|
Mohammad mohsen Keshmirshekan, MD
|
|
11:14
-
11:19
|
Quantitative Retinal Flow and Choriocapillary Flow in Normal Healthy Subjects Using Optical Coherence Tomography Angiography
|
Reza Mirshahi, MD
|
|
11:21
-
11:26
|
Optical Coherence Tomography Angiography of Macular Telangiectasia Type 2
|
Ahmad Mirshahi, MD
|
|
11:28
-
11:33
|
The Quantitative Measurements of Vascular Density and Flow of Optic Nerve Head in Normal Eyes Using Optical Coherence Tomography Angiography
|
Fatemeh Bazvand, MD
|
|
11:35
-
11:40
|
Surgery Outcome in Giant Retinal Tear Patients :Ten Years Experience
|
Sayyed amirpooya Alemzadeh, MD
|
|
11:42
-
11:47
|
Incidence and Risk Factors for Retinopathy of Prematurity in East South of Iran
|
Zahra Nezamdoust, MD
|
|
11:49
-
11:54
|
Intravitreal Injection of Expanile Sulfur Hexafluoride and Head Maneuvering for the Treatment of Vitreomacular Traction
|
Mehdi Modarreszadeh, MD
|
|
11:56
-
12:01
|
Effects of Intravitreal Injection of Bevacizumab With or Without Anterior Chamber Paracentesis on Intraocular Pressure and Peripapillary Retinal Nerve Fiber Layer Thickness: A Prospective Study
|
Saeed Karimi, MD
|
|
12:03
-
12:08
|
Post Pars Plana Vitrectomy Endophthalmitis
|
Ali Tabatabaei, MD
|
|
12:10
-
12:15
|
Minimal Dose of Intravitreal Bevacizumab (0.25 mg/0.01 ml) in the Treatment of Retinopathy of Prematurity
|
Ali reza Khoda Bandeh, MD
|
|
12:17
-
12:22
|
Anti-VEGF Drugs Effect RPE Cells Under Oxidative Stress
|
Mahdy Ranjbar, MD
|
|
12:23
-
12:30
|
Questions & Answers
|
|